Michael Herdman

1.9k total citations
38 papers, 1.4k citations indexed

About

Michael Herdman is a scholar working on Pulmonary and Respiratory Medicine, Economics and Econometrics and Physiology. According to data from OpenAlex, Michael Herdman has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Economics and Econometrics and 8 papers in Physiology. Recurrent topics in Michael Herdman's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Urinary Bladder and Prostate Research (6 papers) and Asthma and respiratory diseases (6 papers). Michael Herdman is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Urinary Bladder and Prostate Research (6 papers) and Asthma and respiratory diseases (6 papers). Michael Herdman collaborates with scholars based in Spain, United Kingdom and Netherlands. Michael Herdman's co-authors include Xavier Badı́a, C.J. Trigg, Judith Duddle, Jan J.V. Busschbach, Moisés A. Calderón, Tessa Kennedy‐Martin, Kristina S. Boye, Wolfgang Greiner, Antonio Diaz-Prieto and Eva Farrero and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Michael Herdman

35 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael Herdman	502	328	291	167	145	38	1.4k
Marie‐Hélène Lafeuille	321 0.6×	411 1.3×	220 0.8×	102 0.6×	145 1.0×	148	2.0k
France Vrijens	304 0.6×	211 0.6×	174 0.6×	103 0.6×	130 0.9×	78	1.2k
Tripthi Kamath	498 1.0×	316 1.0×	63 0.2×	50 0.3×	289 2.0×	22	2.0k
Laurent Laforest	798 1.6×	681 2.1×	145 0.5×	191 1.1×	232 1.6×	77	1.5k
Marriner S. Eccles	131 0.3×	104 0.3×	214 0.7×	100 0.6×	131 0.9×	11	1.2k
Claire McKenna	148 0.3×	132 0.4×	330 1.1×	46 0.3×	311 2.1×	50	1.2k
Matthew Reaney	241 0.5×	50 0.2×	203 0.7×	312 1.9×	217 1.5×	106	2.0k
Manan Shah	298 0.6×	575 1.8×	87 0.3×	24 0.1×	348 2.4×	78	1.7k
G. Duru	386 0.8×	248 0.8×	70 0.2×	67 0.4×	120 0.8×	43	1.3k
Deborah Fitzsimmons	422 0.8×	385 1.2×	184 0.6×	17 0.1×	525 3.6×	88	2.2k

Countries citing papers authored by Michael Herdman

Since Specialization

Citations

This map shows the geographic impact of Michael Herdman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Herdman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Herdman more than expected).

Fields of papers citing papers by Michael Herdman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Herdman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Herdman. The network helps show where Michael Herdman may publish in the future.

Co-authorship network of co-authors of Michael Herdman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Herdman. A scholar is included among the top collaborators of Michael Herdman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Herdman. Michael Herdman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Verstraete, Janine, et al.. (2025). Multinational stakeholder engagement to inform future development and refinement of the EuroQol toddler and infant populations (EQ-TIPS). The European Journal of Health Economics.

Busschbach, Jan J.V., et al.. (2024). Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19. The European Journal of Health Economics. 26(3). 337–351. 5 indexed citations

Mariette, Xavier, Francesca Barone, Chiara Baldini, et al.. (2022). A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome. JCI Insight. 7(23). 70 indexed citations

Bouma, Gerben, Michael Herdman, Michael Byrne, et al.. (2021). Structure and Functional Characterization of a Humanized Anti-CCL20 Antibody following Exposure to Serum Reveals the Formation of Immune Complex That Leads to Toxicity. The Journal of Immunology. 206(5). 1067–1076. 3 indexed citations

Herdman, Michael, et al.. (2020). Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L. Journal of Patient-Reported Outcomes. 4(1). 22–22. 14 indexed citations

Herdman, Michael, et al.. (2020). Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. The European Journal of Health Economics. 21(8). 1245–1257. 201 indexed citations

Vela‐Navarrete, R., Antonio Alcaraz, A. Rodrı́guez-Antolı́n, et al.. (2018). Efficacy and safety of a hexanic extract of Serenoa repens (Permixon ^® ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia ( LUTS / BPH ): systematic review and meta‐analysis of randomised controlled trials and observational studies. British Journal of Urology. 122(6). 1049–1065. 62 indexed citations

Maximiano, Constanza, et al.. (2018). An exploratory, large-scale study of pain and quality of life outcomes in cancer patients with moderate or severe pain, and variables predicting improvement. PLoS ONE. 13(4). e0193233–e0193233. 10 indexed citations

Herdman, Michael, et al.. (2016). Identifying Improved and Non-improved Aspects of Health-related Quality of Life After Liver Transplantation Based on the Assessment of the Specific Questionnaire Liver Disease Quality of Life. Transplantation Proceedings. 48(1). 132–137. 6 indexed citations

10.

Devlin, Nancy, Michael Herdman, Marco Pavesi, et al.. (2015). Health-Related Quality Of Life (Hrqol) Benefits Of Enzalutamide In Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc): An In-Depth Analysis Of Eq-5d Data From The Prevail Trial. Value in Health. 18(7). A475–A475. 1 indexed citations

11.

Herdman, Michael, Marco Pavesi, Nancy Devlin, et al.. (2014). Using Eq-5d-3l And Oab-5d To Assess Changes In Health-Related Quality Of Life (Hrqol) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph). Value in Health. 17(3). A295–A295.

12.

Valero, Antonio, et al.. (2011). Measuring outcomes in allergic rhinitis: psychometric characteristics of a Spanish version of the congestion quantifier seven-item test (CQ7). Health and Quality of Life Outcomes. 9(1). 14–14. 9 indexed citations

13.

Casado, Alfonso, et al.. (2008). Cost-effectiveness of citicoline versus conventional treatment in acute ischemic stroke. Expert Review of Pharmacoeconomics & Outcomes Research. 8(2). 151–157. 10 indexed citations

14.

Herdman, Michael, et al.. (2007). Validation of the Spanish Version of the Liver Disease Quality of Life Instrument Among Candidates for Liver Transplant. Transplantation Proceedings. 39(7). 2274–2277. 7 indexed citations

15.

Badı́a, Xavier, et al.. (2001). Using the EuroQol-5D to measure changes in quality of life 12 months after discharge from an intensive care unit. Intensive Care Medicine. 27(12). 1901–1907. 170 indexed citations

16.

Garcı́a-Losa, Manuel, et al.. (2001). Effect of Mode of Administration on I–PSS Scores in a Large BPH Patient Population. European Urology. 40(4). 451–457. 11 indexed citations

17.

Badı́a, Xavier, et al.. (1998). Adaptación transcultural al español del cuestionario Dermatology Life Quality Index (DLQI): El Índice de Calidad de Vida en Dermatología. Actas Dermo-Sifiliográficas. 89(12). 692–700. 42 indexed citations

18.

Trigg, C.J., et al.. (1994). Placebo-Controlled Immunopathologic Study of Four Months of Inhaled Corticosteroids in Asthma. American Journal of Respiratory and Critical Care Medicine. 150(1). 17–22. 251 indexed citations

19.

Duddle, Judith, et al.. (1994). Comparison of a new antihistaminic and antiallergic compound KW 4679 with terfenadine and placebo on skin and nasal provocation in atopic individuals. Clinical & Experimental Allergy. 24(10). 955–959. 7 indexed citations

20.

Herdman, Michael, H. Ferguson, K. J. Thomas, C.J. Trigg, & R.J. Davies. (1993). The effect of salbutamol controlled release on airways responsiveness to inhaled methacholine in mild asthmatic subjects. Respiratory Medicine. 87(1). 23–27. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact